Related Experiment Videos

[Percutaneous mitral and aortic valve dilatation in the same session]

A Ramondo1, A Barchitta, L Budano

  • 1Servizio di Emodinamica Cardiologia Interventistica, Università degli Studi, Padova.

Giornale Italiano Di Cardiologia
|October 17, 1998
PubMed

Insights

Percutaneous balloon valvuloplasty offers good long-term results for rheumatic mitral and aortic stenosis. However, it shows limited success in elderly degenerative aortic stenosis, necessitating careful patient selection.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Percutaneous balloon valvuloplasty (PBV) is a recognized treatment for rheumatic mitral and aortic stenosis.
  • Its efficacy in elderly degenerative aortic stenosis is limited due to suboptimal long-term outcomes.
  • PBV is typically reserved for high-risk surgical patients.

Observation:

  • Three cases of simultaneous mitral and aortic PBV were analyzed.
  • Etiologies included rheumatic (two cases) and mixed rheumatic-degenerative (one case).
  • No immediate major complications were reported.

Findings:

  • PBV successfully reduced mitral and aortic gradients, increasing valve areas and cardiac index post-procedure.
  • Rheumatic valvulopathy cases demonstrated sustained positive results at seven-year follow-up.
  • The degenerative component in the third case led to restenosis within a few years.

Implications:

  • Simultaneous mitral and aortic PBV can be effective for rheumatic valvular stenosis.
  • Long-term success is dependent on the underlying etiology, with degenerative disease posing a challenge.
  • This procedure may be a viable option for select high-risk patients with mixed valvular disease.

Related Concept Videos